Abstract
Medical Science Liaisons (MSLs) serve a critical role in bridging biopharmaceutical science with real-world patient care. As a primary care Key Opinion Leader (KOL), I’ve had the opportunity to collaborate with MSLs across multiple therapeutic areas and companies. This article provides an experiential lens into the evolving relationship between MSLs and KOLs. It outlines actionable strategies MSLs can use to improve clinical partnerships, enhance scientific exchange, and ultimately impact patient outcomes through stronger collaboration and tailored engagement.
Introduction
The relationship between a Medical Science Liaison (MSL) and a Key Opinion Leader (KOL) has the potential to be one of the most impactful partnerships in the healthcare ecosystem. As a KOL practicing in primary care, I rely on clinical data, practice guidelines, and treatment innovations that are both evidence-based and practical for real-world implementation. MSLs are uniquely positioned to support that mission. This article will offer my perspective as a practicing clinician and KOL to help MSLs understand what we value most, how they can improve interactions, and how strategic collaboration can translate into real-world patient outcome improvements.
Understanding the KOL Perspective
KOLs sit at the intersection of clinical care and clinical influence. We manage complex patient panels while serving as educators, researchers, and system-level advisors. We are time-constrained, evidence-hungry, and always seeking data that can immediately be translated into care decisions. From my viewpoint, MSLs are most impactful when they:
- Understand my patient population and clinical priorities
- Bring information that is timely, actionable, and practice-relevant
- Engage in longitudinal, trust-based relationships—not one-time exchanges
An ideal MSL-KOL interaction feels like a strategic partnership built on shared goals, rather than a transactional or product-driven exchange.
Elevating the MSL-KOL Relationship
- Lead with Clinical Curiosity
A successful MSL starts with listening. MSLs who begin with “Tell me more about your practice” earn trust faster. Learn what matters to us. For example, I care deeply about health equity, preventative health screenings and wellness, and integrating digital tools for chronic care. MSLs who recognize those areas and bring aligned data or insights are far more effective. One-size-fits-all approaches rarely succeed. Personalization and perpetration make a difference. MSLSs should ask meaningful questions, revisit past conversations, and arrive informed. From my experience, I respond best to MSLs who value my time and offer real, practice-relevant insights. - Translate Data into Decisions
MSLs should serve as conduits of meaningful, evidence-based insights. Beyond presenting data, successful MSLs synthesize clinical implications, identify practice gaps, and encourage thoughtful discussion. For example, discussing real-world data related to my primary care population, rather than purely trial-based efficacy results, has significantly enhanced my ability to incorporate new interventions into practice. KOLs need clinical trial data contextualized for our patient populations. Don’t just present efficacy endpoints—discuss limitations, subgroup nuances, and real-world application. The best MSLs help connect the dots from data to action. - Be a Conduit for Innovation
MSLs are at the forefront of emerging science. Introduce digital health tools, predictive analytics, and AI-enabled decision support systems. These tools help us improve workflows and outcomes. For example, MSLs who bring value-based care insights or real-world data are helping me transform how I practice. MSLs who bring value through visual dashboards, measure-based education, or integration of clinical decision support tools into the workflow make a larger impact. MSLs must evolve with the health tech space, understanding clinical quality measures and the metrics that matter in value-based care. - Support Research and Thought Leadership
MSLs who recognize KOLs as collaborators in knowledge generation rather than passive recipients of information build trust. Whether it’s supporting investigator-initiated trials or connecting KOLs with emerging research opportunities, proactive thought partnership is powerful. Encourage investigator-initiated trials (IITs), connect us with research opportunities, and help us disseminate clinical insights. MSLs who proactively support these efforts deepen their scientific partnership with KOLs.
Improving Patient Outcomes Through Collaboration
Ultimately, the collaboration between MSLs and KOLs must translate into patient benefit. Whether by elevating the standard of care, introducing therapeutic innovations, or co-creating educational content for frontline clinicians, this relationship should center around improving health outcomes. KOLs don’t need more meetings—we need meaningful engagement that changes how we treat patients. Strong MSL relationships support:
- Faster integration of novel therapies
- Evidence-based prescribing
- Quality improvement efforts within health systems
- Access to cutting-edge data for underserved populations
When MSLs align their support with what we’re already trying to improve, the results are transformational.
Recommendations for MSLs
- Be consistent: Build trust through regular touchpoints, not just during product launches.
- Stay clinically grounded: Speak the language of outcomes, not sales.
- Offer value beyond the visit: Summarize insights, share new publications, and connect us with broader thought leadership opportunities.
- Embrace two-way dialogue: Ask for our feedback and be open to how your science is perceived in real-world care.
Figure 1
Figure 1. Ideal MSL-KOL Collaboration Framework. This diagram illustrates the optimal progression of collaboration between a Medical Science Liaison (MSL) and a Key Opinion Leader (KOL), beginning with initial engagement and evolving through scientific exchange, research support, and data integration, ultimately leading to improved patient outcomes.
Conclusion
The MSL-KOL partnership is an underutilized lever for improving patient outcomes. From my perspective as a primary care KOL, the most impactful MSLs bring curiosity, humility, and strategic insight to every interaction. They support not only the science but the clinician behind it. If we want to elevate healthcare together, we must move beyond the transactional and toward the transformational. Let’s make collaboration the standard, not the exception.
Disclaimer: This article was created with the help of AI (ChatGPT). All concepts and topics were developed by the author.
About the author:
Justin D. Pykare, DNP, APRN, FNP-BC, NI-BC
Justin Pykare is a board-certified Family Nurse Practitioner and serves as the Director of Health Informatics at a Federally Qualified Health Center (FQHC). A four-time graduate of Kent State University, he holds a Doctor of Nursing Practice degree and is board-certified in Health Informatics. With a strong background in clinical leadership, Justin is passionate about leveraging technology to improve patient outcomes, enhance workflows, and support high-quality, value-based care. Outside of work, he enjoys running, exercising, and spending time with his wife and their five children. Justin is deeply committed to his faith, family, and the mission of serving underserved communities through compassionate, innovative care.
Have an opinion on this article? Send a message to the editor.